Inventor
JEFFS ROGER
US16 patents
⚠️ This page may combine multiple inventors who share the name “JEFFS ROGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNITED THERAPEUTICS CORP
15 patentsUS9624156B2Apr 18, 2017
Compounds and methods for delivery of prostacyclin analogs
UNITED THERAPEUTICS CORP30 citations97
US9422223B2Aug 23, 2016
Compounds and methods for delivery of prostacyclin analogs
UNITED THERAPEUTICS CORP44 citations97
US9278901B2Mar 8, 2016
Compounds and methods for delivery of prostacyclin analogs
UNITED THERAPEUTICS CORP47 citations97
US9199908B2Dec 1, 2015
Compounds and methods for delivery of prostacyclin analogs
UNITED THERAPEUTICS CORP46 citations97
US7999007B2Aug 16, 2011
Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
UNITED THERAPEUTICS CORP52 citations95
US10080730B2Sep 25, 2018
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
UNITED THERAPEUTICS CORP23 citations94
US10071123B2Sep 11, 2018
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
UNITED THERAPEUTICS CORP21 citations94
US10016463B2Jul 10, 2018
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
UNITED THERAPEUTICS CORP19 citations94
US11141393B2Oct 12, 2021
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
UNITED THERAPEUTICS CORP9 citations85
US10842823B2Nov 24, 2020
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
UNITED THERAPEUTICS CORP8 citations84
US11839596B2Dec 12, 2023
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
UNITED THERAPEUTICS CORP3 citations73
US11839631B2Dec 12, 2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
UNITED THERAPEUTICS CORP3 citations73
US12310992B2May 27, 2025
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
UNITED THERAPEUTICS CORP0 citations62
US12274684B2Apr 15, 2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
UNITED THERAPEUTICS CORP0 citations62
US11666602B2Jun 6, 2023
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
UNITED THERAPEUTICS CORP1 citations62